biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > so is that the end of JD? Prophet?

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 19, 2023 8:20pm

65 Views

Post# 35596639

RE:RE:RE:RE:RE:RE:RE:RE:RE:so is that the end of JD? Prophet?

Are the brains of hockey players made entirely of vulcanized rubber, TT, or just mostly?

Which begs the question, are the blood-brain barriers in hockey players made of rubber?

It's been discussed that, as standard of care for breast cancer, xB3-001 would likely have prophylactic value with respect to brain metastases, much as rubber has in other services.

xB3-001 might provide double protection for you, TT.

jd

<< Previous

Bullboard Posts

Next >>

How Canadian investors can benefit from flow-through shares